Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Dose Range: 0.64.5 mg weekly with gradual titration every 2 weeks
Unlike pharmacological interventions that target single receptors or pathways, GHK-Cus multi-gene modulation touches many of the hallmarks of aging simultaneously: Genomic instability (DNA repair gene upregulation) Epigenetic alterations (chromatin remodeling via altered transcription factor activity) Loss of proteostasis (chaperone and proteasome pathway modulation) Cellular senescence (anti-apoptotic and anti-senescence gene networks) Altered intercellular communication (anti-inflammatory cytokine modulation) This positions GHK-Cu within what researchers increasingly call multi-hallmark peptide therapy a conceptual framework that prioritizes compounds acting across multiple aging mechanisms simultaneously
Glutathione IV Therapy: Benefits, Process, and Results at DripGym Glutathione intravenous (IV) drip continues to be a popular type of IV therapy, given glutathiones reputation as a master antioxidant that delivers health and beauty benefits
GHK-Cu is not currently approved by the Therapeutic Goods Administration (TGA) for therapeutic use in Australia
